Navigation Links
Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
Date:11/16/2009

therapy where cancer drugs are actively pumped out of cancer cells," said David Sherris, Ph.D., President and CEO of Paloma Pharmaceuticals. "This work adds to our mounting compendium of data showing P529 as a potent oral anti-tumor agent in variety of tumor animal models including breast, prostate and glioblastoma," said Dr. Sherris.

About the PI3K/Akt/mTOR Pathway

The PI3K/Akt/mTOR pathway has been implicated in a wide variety of biological responses and is considered a major therapeutic target in cancer. Activation of this signaling pathway, via direct or indirect mutagenic events, is common in many types of human cancer resulting in deregulation of PI3K/Akt/mTOR pathway in cancer. Thus, agents capable of inhibiting the PI3K/Akt/mTOR pathway are attractive targets for therapeutic intervention in cancer. Central within the signalling pathway are two distinct protein complexes, one of which regulates growth through the signal transduction protein S6K, TORC1, and the other that regulates cell survival through Akt, TORC2. These complexes define both rapamycin-sensitive and insensitive branches of the PI3K/Akt/mTOR pathway. Inhibition of the TORC2 pathway suppresses the formation of tumors driven by the loss of the PTEN tumor suppressor, a gene which when lost contributes to carcinogenicity. Inhibitors of TORC2 may then have beneficial effects as anti-cancer agents without toxicity to normal tissues since loss of TORC2 through genetic alteration does not appear to affect normal tissue. TORC1 antagonists as rapamycin and other such rapalogs have shown activity in both animal models of cancer and in human clinical trials. As inhibition of both TORC1 and TORC2 should result in more complete inhibition of PI3K/Akt/mTOR signaling up-regulated in cancer, dual inhibitors are of active interest for pharmaceutical development.

About Paloma Pharmaceuticals

Paloma Pharmaceuticals, Inc. is an early stage drug development company
'/>"/>

SOURCE Paloma Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
2. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... WASHINGTON , March 1, 2015  USPlabs ... of the following and states that media reports ... false: On Saturday, February 28, 2015, ... issued a Public Notification on the contamination of ... Super Thermogenic (referred to below as "OEP") with ...
(Date:2/27/2015)... , Feb. 27, 2015 Roughly three-quarters ... very confident substituting an interchangeable biosimilar for its ... the same nonproprietary name, according to a survey ... (AMCP,s) Journal of Managed Care & Specialty ... 25 percent of pharmacists would feel as confident ...
(Date:2/27/2015)... Feb. 27, 2015 Pharmaceutical and biotech marketers ... products for the same indication. This can be a ... to prevent one of their brands from gaining market ... to recent research by benchmarking firm, Best Practices, LLC, ... brands rather than together as part of a franchise. ...
Breaking Medicine Technology:OEP Product Is Counterfeit 2Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2
... 2012 Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company focused ... treatments for women,s health and cancer, announced today that ... that the Phase 3 trial of Menerba (MF101) could ... clinical safety and tolerability data. Menerba is Bionovo,s oral ...
... leaders of "America,s pastime," a free open-source screen-reading software company, ... Camp Abilities have in common? All have taken successful strides ... are blind or visually impaired, which is why they were ... by the American Foundation for the Blind (AFB). Chosen ...
Cached Medicine Technology:Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 2Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 3Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 4American Foundation for the Blind Announces 2012 Access Award Winners 2American Foundation for the Blind Announces 2012 Access Award Winners 3
(Date:2/28/2015)... 28, 2015 Gerald “Solutionman” Haman surveyed ... or barriers to innovative thinking. “The #1 block ... lack of tools,” reports Haman, who created the Thinkubator ... of people felt that they did not have enough ... and resources to stimulate innovation. , Solutionman’s monthly “Accelerating ...
(Date:2/28/2015)... 2015 Mew and Company, a Vancouver ... now provide business consulting services in addition to a ... planning and succession planning. Company finances are a complicated ... On top of this, complex Canadian tax laws can ... As a result, Mew and Company works to advise ...
(Date:2/28/2015)... Bethesda, MD (PRWEB) February 28, 2015 ... will present its annual awards at the International Symposium ... Dinner will be held at the Hyatt Regency Bethesda ... honored for their dedicated work and commitment to the ... of the Year Award will be presented to Miriam ...
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... 2015 The noted Toronto plastic surgeon ... was recently featured in the January/February 2015 issue of ... David Ellis was featured in an article entitled “Get ... enhancements that Kim Cattrall has possibly undergone to maintain ... is smooth without horizontal lines or frown line creases, ...
Breaking Medicine News(10 mins):Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:Dr. David Ellis Featured In Elevate Magazine 2
... major science prize, Pauline Ashley Prize 2007 was awarded to a ... in the human brain that could help to single out somebody's ... together and also responsible for training the brain to hear better ... to identify or hear another person's voice in a noisy room ...
... backlogs of patients for important surgeries has alerted ... the issue. According to the complaint, operations ... been put on the back burner, with patients ... of evidence to support these complaints has spurred ...
... is about to embark upon a health revolution that ... for paraplegics to walk again.// ,This is ... seven medical advances which they consider will transform lives. ... are at the forefront of the coming breakthroughs. ...
... Structural abnormalities were found in a particular brain ... to a study conducted// at the Laboratory for ... Studies. ,Williams syndrome is a rare ... therefore spend hours listening to or making music. ...
... the National Breast Feeding week included an All-Ireland Conference ... pose a major hurdle to ensuring more number of ... of the lowest breast feeding rates. ,Internationally acclaimed ... Toronto, said, “In the case of infant feeding, if ...
... curcumin — a chemical found in curry and turmeric ... //of amyloid beta, which form the plaques found in ... of the Journal of Alzheimer’s Disease, the early laboratory ... Alzheimer’s disease by enhancing the natural function of the ...
Cached Medicine News:Health News:Tune Your Brain to Hear Another in a Noisy Ambience 2Health News:Tune Your Brain to Hear Another in a Noisy Ambience 3Health News:Tune Your Brain to Hear Another in a Noisy Ambience 4Health News:Age of Medical Miracles has come upon us 2Health News:Chemical in Curry May Help Immune System Clear Plaques Found in Alzheimer's 2
... site introduces the DiamondTome™ Skin Resurfacing ... unique DiamondTome™ Wands, an evolution in ... to smoother, more youthful skin. , ... the benefits of DiamondTome's™ innovative approach ...
... is a state-of-the-art hair reduction and ... specially designed for use within a ... features and economy in a single ... treatment of unwanted hair, photo rejuvenation ...
... Start or expand your aesthetic practice ... SR, the cost-effective system that's gentle, powerful ... seeking the exciting benefits of IPL Skin ... system promises to be an indispensable tool ...
Standard Lipo-tubing...
Medicine Products: